ResearcherUniversity of MinnesotaActive in the last 2 years

Brett Roach

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4232-5992; OpenAlex author ID A5013119443. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

Targeting pancreatic cancer with adenoviral vectors equipped with transgenes. Co-author DOI 10.1158/1535-7163.mct-25-1231 ↗
Obesity and Pancreatic Cancer: Recent Progress in Epidemiology, Mechanisms and Bariatric Surgery. Co-author DOI 10.3390/biomedicines10061284 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Masato Yamamoto · 2 shared papers, 2022–2026 · strength 0.52
- Paper Targeting pancreatic cancer with adenoviral vectors equipped with transgenes. DOI 10.1158/1535-7163.mct-25-1231 ↗
- Paper Obesity and Pancreatic Cancer: Recent Progress in Epidemiology, Mechanisms and Bariatric Surgery. DOI 10.3390/biomedicines10061284 ↗
Ingunn M. Stromnes · 1 shared paper, 2026 · strength 0.33
- Paper Targeting pancreatic cancer with adenoviral vectors equipped with transgenes. DOI 10.1158/1535-7163.mct-25-1231 ↗
Mizuho Sato‐Dahlman · 1 shared paper, 2026 · strength 0.33
- Paper Targeting pancreatic cancer with adenoviral vectors equipped with transgenes. DOI 10.1158/1535-7163.mct-25-1231 ↗
Shuhei Shinoda · 1 shared paper, 2022 · strength 0.19
- Paper Obesity and Pancreatic Cancer: Recent Progress in Epidemiology, Mechanisms and Bariatric Surgery. DOI 10.3390/biomedicines10061284 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.